Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew G Stephen

Showing results (31-40 of 96) with videos related to

Pageof 10
Sort By:
Journal of Virology|December 17, 2008
Assembly properties of human immunodeficiency virus type 1 Gag-leucine zipper chimeras: implications for retrovirus assemblyRachael M Crist, Siddhartha A K Datta, Andrew G Stephen, et al.
Nucleic Acids Research|July 10, 2007
Correlation between binding rate constants and individual information of E. coli Fis binding sitesRyan K Shultzaberger, Lindsey R Roberts, Ilya G Lyakhov, et al.
Organic Letters|October 20, 2006
Hydrazone- and hydrazide-containing N-substituted glycines as peptoid surrogates for expedited library synthesis: application to the preparation of Tsg101-directed HIV-1 budding antagonistsFa Liu, Andrew G Stephen, Catherine S Adamson, et al.
Cancer Research|October 6, 2005
Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activityDehe Kong, Eun Jung Park, Andrew G Stephen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2007
Cell type-specific, topoisomerase II-dependent inhibition of hypoxia-inducible factor-1alpha protein accumulation by NSC 644221Mark Creighton-Gutteridge, John H Cardellina, Andrew G Stephen, et al.
Biophysical Journal|March 9, 2019
KRAS Prenylation Is Required for Bivalent Binding with Calmodulin in a Nucleotide-Independent MannerConstance Agamasu, Rodolfo Ghirlando, Troy Taylor, et al.
Molecular Cancer Therapeutics|June 23, 2021
Development of a High-throughput NanoBRET Screening Platform to Identify Modulators of the RAS/RAF InteractionDavid E Durrant, Emily A Smith, Ekaterina I Goncharova, et al.
Molecular Cell|November 8, 2022
RASopathy mutations provide functional insight into the BRAF cysteine-rich domain and reveal the importance of autoinhibition in BRAF regulationRussell Spencer-Smith, Elizabeth M Terrell, Christine Insinna, et al.
Virology|July 15, 2009
Functional role of Alix in HIV-1 replicationKen Fujii, Utpal M Munshi, Sherimay D Ablan, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2020
The small molecule BI-2852 induces a nonfunctional dimer of KRASTimothy H Tran, Patrick Alexander, Srisathiyanarayanan Dharmaiah, et al.
Pageof 10

Showing results (31-40 of 96) with videos related to

Sort By:
Pageof 10
Journal of Virology|December 17, 2008
Assembly properties of human immunodeficiency virus type 1 Gag-leucine zipper chimeras: implications for retrovirus assemblyRachael M Crist, Siddhartha A K Datta, Andrew G Stephen, et al.
Nucleic Acids Research|July 10, 2007
Correlation between binding rate constants and individual information of E. coli Fis binding sitesRyan K Shultzaberger, Lindsey R Roberts, Ilya G Lyakhov, et al.
Organic Letters|October 20, 2006
Hydrazone- and hydrazide-containing N-substituted glycines as peptoid surrogates for expedited library synthesis: application to the preparation of Tsg101-directed HIV-1 budding antagonistsFa Liu, Andrew G Stephen, Catherine S Adamson, et al.
Cancer Research|October 6, 2005
Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activityDehe Kong, Eun Jung Park, Andrew G Stephen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2007
Cell type-specific, topoisomerase II-dependent inhibition of hypoxia-inducible factor-1alpha protein accumulation by NSC 644221Mark Creighton-Gutteridge, John H Cardellina, Andrew G Stephen, et al.
Biophysical Journal|March 9, 2019
KRAS Prenylation Is Required for Bivalent Binding with Calmodulin in a Nucleotide-Independent MannerConstance Agamasu, Rodolfo Ghirlando, Troy Taylor, et al.
Molecular Cancer Therapeutics|June 23, 2021
Development of a High-throughput NanoBRET Screening Platform to Identify Modulators of the RAS/RAF InteractionDavid E Durrant, Emily A Smith, Ekaterina I Goncharova, et al.
Molecular Cell|November 8, 2022
RASopathy mutations provide functional insight into the BRAF cysteine-rich domain and reveal the importance of autoinhibition in BRAF regulationRussell Spencer-Smith, Elizabeth M Terrell, Christine Insinna, et al.
Virology|July 15, 2009
Functional role of Alix in HIV-1 replicationKen Fujii, Utpal M Munshi, Sherimay D Ablan, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2020
The small molecule BI-2852 induces a nonfunctional dimer of KRASTimothy H Tran, Patrick Alexander, Srisathiyanarayanan Dharmaiah, et al.
Pageof 10